Therapy Management Using Modified 2-Weeks-On/1-Week-Off Dosing Schedule in Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario
Allman, Kimberly D, Ryan, Joanne C, Clair, Andrew, Yenser-Wood, Sarah
Published in Journal of the advanced practitioner in oncology (01.07.2019)
Published in Journal of the advanced practitioner in oncology (01.07.2019)
Get full text
Journal Article
A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy (RT) in men with PSA recurrent prostate cancer (PC) after radical prostatectomy (RP)
Armstrong, Andrew J., Halabi, Susan, Healy, Patrick, Lee, Robert, Koontz, Bridget F., Moul, Judd W., Mundy, Kelly, Creel, Patricia, Yenser Wood, Sarah, Davis, Kristen, Reimer, Brooke, Nguyen, Minh, Spitz, Avery N., Bratt, Ellen, Kim, Sung, Tran, Phuoc T., Stein, Mark N., Carducci, Michael Anthony, George, Daniel J.
Published in Journal of clinical oncology (01.03.2015)
Published in Journal of clinical oncology (01.03.2015)
Get full text
Journal Article
A Phase Ib Study of Combined VEGFR and mTOR Inhibition With Vatalanib and Everolimus in Patients With Advanced Renal Cell Carcinoma
Bitting, Rhonda L, Healy, Patrick, Creel, Patricia A, Turnbull, James, Morris, Karla, Wood, Sarah Yenser, Hurwitz, Herbert I, Starr, Mark D, Nixon, Andrew B, Armstrong, Andrew J, George, Daniel J
Published in Clinical genitourinary cancer (01.08.2014)
Published in Clinical genitourinary cancer (01.08.2014)
Get full text
Journal Article